Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of mycobacterium tuberculosis

mBio

Volumn 5, Issue 5, 2014, Pages

  Prados Rosales, Rafael ^a   Carreño, Leandro J ^a,d   Batista Gonzalez, Ana ^a   Baena, Andres ^b   Venkataswamy, Manjunatha M ^a,e   Xu, Jiayong ^a   Yu, Xiaobo ^c   Wallstrom, Garrick ^c   Mitchell Magee, D ^c   LaBaer, Joshua ^c   Achkar, Jacqueline M ^a   Jacobs, William R ^a   Chan, John ^a   Porcelli, Steven A ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c ARIZONA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CHILE   (Chile)

^e NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; IMMUNOGLOBULIN G2C ANTIBODY; INTERLEUKIN 2; LIPOPROTEIN; LPPX PROTEIN; LPQH PROTEIN; PSTS1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VAPC6 PROTEIN; BACTERIUM ANTIBODY; IMMUNOLOGICAL ADJUVANT; MEMBRANE PROTEIN; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; LUNG TUBERCULOSIS; MEMBRANE VESICLE; MOUSE; MYCOBACTERIUM MEMBRANE VESICLE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS H37RV; NONHUMAN; ANIMAL; BLOOD; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INNATE IMMUNITY; MYCOBACTERIUM BOVIS; TUBERCULOSIS;

MUS; MYCOBACTERIUM TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BCG VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, HUMORAL; IMMUNITY, INNATE; LIPOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TOLL-LIKE RECEPTOR 2; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84908441261     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01921-14     Document Type: Article

References (28)

1. Kuehn MJ, Kesty NC. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19:2645-2655. http://dx.doi.org/ 10.1101/gad.1299905.
2. Oliveira DL, Nakayasu ES, Joffe LS, Guimarães AJ, Sobreira TJ, Nosanchuk JD, Cordero RJ, Frases S, Casadevall A, Almeida IC, Nimrichter L, Rodrigues ML. 2010. Biogenesis of extracellular vesicles in yeast: many questions with few answers. Commun. Integr. Biol. 3:533-535. http://dx.doi.org/10.4161/cib.3.6.12756.
3. Oliveira DL, Nakayasu ES, Joffe LS, Guimarães AJ, Sobreira TJ, Nosanchuk JD, Cordero RJ, Frases S, Casadevall A, Almeida IC, Nimrichter L, Rodrigues ML. 2010. Characterization of yeast extracellular vesicles: evidence for the participation of different pathways of cellular traffic in vesicle biogenesis. PLoS One 5:e11113. http://dx.doi.org/ 10.1371/journal.pone.0011113.
4. Rodrigues ML, Nakayasu ES, Oliveira DL, Nimrichter L, Nosanchuk JD, Almeida IC, Casadevall A. 2008. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot. Cell 7:58-67. http://dx.doi.org/10.1128/EC.00370 -07.
5. Prados-Rosales R, Baena A, Martinez LR, Luque-Garcia J, Kalscheuer R, Veeraraghavan U, Camara C, Nosanchuk JD, Besra GS, Chen B, Jimenez J, Glatman-Freedman A, Jacobs WR, Jr, Porcelli SA, Casadevall A. 2011. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J. Clin. Invest. 121:1471-1483. http://dx.doi.org/10.1172/JCI44261.
6. Rivera J, Cordero RJ, Nakouzi AS, Frases S, Nicola A, Casadevall A. 2010. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc. Natl. Acad. Sci. U. S. A. 107:19002-19007. http://dx.doi.org/10.1073/pnas.1008843107.
7. Olaya-Abril A, Prados-Rosales R, McConnell MJ, Martin-Pena R, Gonzalez-Reyes JA, Jimenez-Munguia I, Gomez-Gascon L, Fernandez J, Luque-Garcia JL, Garcia-Lidon C, Estevez H, Pachon J, Obando I, Casadevall A, Pirofski LA, Rodriguez-Ortega MJ. 2014. Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae. J. Proteomics 106C:46 - 60. http://dx.doi.org/ 10.1016/j.jprot.2014.04.023.
8. Brown L, Kessler A, Cabezas-Sanchez P, Luque-Garcia JL, Casadevall A. 2014. Extracellular vesicles produced by the Gram-positive bacterium Bacillus subtilis are disrupted by the lipopeptide surfactin. Microbiol. Mol. 93:183-198.
9. WHO. 2011. Global tuberculosis control: WHO report. WHO, Geneva, Switzerland.
10. Kaufmann SH. 2010. Future vaccination strategies against tuberculosis: thinking outside the box. Immunity 33:567-577. http://dx.doi.org/ 10.1016/j.immuni.2010.09.015.
11. Holst J, Martin D, Arnold R, Huergo CC, Oster P, O'Hallahan J, Rosenqvist E. 2009. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27(Suppl 2):B3-12. http://dx.doi.org/10.1016/j.vaccine.2009.10.014.
12. Fransen F, Stenger RM, Poelen MC, van Dijken HH, Kuipers B, Boog CJ, van Putten JP, van Els CA, van der Ley P. 2010. Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS One 5:e15692. http://dx.doi.org/10.1371/journal.pone.0015692.
13. Alaniz RC, Deatherage BL, Lara JC, Cookson BT. 2007. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179:7692-7701. http:// dx.doi.org/10.4049/jimmunol.179.11.7692.
14. Schild S, Nelson EJ, Camilli A. 2008. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect. Immun. 76:4554-4563. http://dx.doi.org/10.1128/IAI.00532-08.
15. Sotolongo F, Campa C, Casanueva V, Fajardo EM, Cuevas IE, González N. 2007. Cuban meningococcal BC vaccine: experiences & contributions from 20 years of application. MEDICC Rev. 9:16-22.
16. Rodriguez L, Tirado Y, Reyes F, Puig A, Kadir R, Borrero R, Fernandez S, Reyes G, Alvarez N, Garcia MA, Sarmiento ME, Norazmi MN, Perez Quinoy JL, Acosta A. 2011. Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice. Vaccine 29:6236-6241. http://dx.doi.org/10.1016/ j.vaccine.2011.06.077.
17. Ramachandran N, Hainsworth E, Bhullar B, Eisenstein S, Rosen B, Lau AY, Walter JC, LaBaer J. 2004. Self-assembling protein microarrays. Science 305:86-90. http://dx.doi.org/10.1126/science.1097639.
18. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129. http://dx.doi.org/10.1146/annurev.immunol.19.1.93.
19. Prados-Rosales R, Weinrick BC, Piqué DG, Jacobs WR, Jr, Casadevall A, Rodriguez GM. 2014. Role for Mycobacterium tuberculosis membrane vesicles in iron acquisition. J. Bacteriol. 196:1250 -1256. http:// dx.doi.org/10.1128/JB.01090-13.
20. Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. 2004. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173:2660-2668. http://dx.doi.org/10.4049/jimmunol.173.4.2660.
21. Fransen F, Hamstra HJ, Boog CJ, van Putten JP, van den Dobbelsteen GP, van der Ley P. 2010. The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease. Infect. Immun. 78:3177-3186. http://dx.doi.org/10.1128/IAI.01311-09.
22. Haneberg B, Dalseg R, Wedege E, Høiby EA, Haugen IL, Oftung F, Andersen SR, Naess LM, Aase A, Michaelsen TE, Holst J. 1998. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect. Immun. 66:1334-1341.
23. Keenan J, Day T, Neal S, Cook B, Perez-Perez G, Allardyce R, Bagshaw P. 2000. A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol. Lett. 182:259-264. http:// dx.doi.org/10.1111/j.1574-6968.2000.tb08905.x.
24. Kesavalu L, Ebersole JL, Machen RL, Holt SC. 1992. Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect. Immun. 60:1455-1464.
25. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, Brunelli B, Pieri A, Santini L, Savino S, Serruto D, Litt D, Kroll S, Welsch JA, Granoff DM, Rappuoli R, Pizza M. 2003. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med. 197:789 -799. http://dx.doi.org/10.1084/ jem.20021911.
26. McConnell MJ, Rumbo C, Bou G, Pachón J. 2011. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 29:5705-5710. http://dx.doi.org/10.1016/j.vaccine.2011.06.001.
27. Schild S, Nelson EJ, Bishop AL, Camilli A. 2009. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect. Immun. 77:472-484. http://dx.doi.org/10.1128/IAI.01139-08.
28. Kim OY, Hong BS, Park KS, Yoon YJ, Choi SJ, Lee WH, Roh TY, Lötvall J, Kim YK, Gho YS. 2013. Immunization with Escherichia coli Outer Membrane Vesicles Protects Bacteria-Induced Lethality via Th1